Comparison of Clinical outcomes between angio-guided spot stenting and angio-guided entire stenting using Zotarolimus eluting stent with the patients with diffuse long coronary lesions.
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0003082
- Lead Sponsor
- Koera University Guro Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 470
1. Age Only patients with stable angina or unstable angina over 19 years
2. Reference diameter = 2.5 mm lesion length = 25 mm
3. De novo lesions with% Diameter stenosis =50%
4. Patient with Core lesion for spot stenting
For definitions of core lesions, see Clinical Trial Methods.
1. Ascitic (aspirin), clopidogrel (Clopidogrel) and anti-platelet agents, such as those who are contraindicated
2. Left-sided lesions (left main lesion, internal diameter stenosis (diameter stenosis) =50%)
3. A recent hematologic disease or white blood cell count of 3000 / mm3 and / or platelet count of 100,000 / mm3. Who show less
4. Severe epicardial disease with a longevity of less than 1 year
5. Those who plan to perform two stenting operations on branch vessels and branch lesions with basilar lesions
6. Patients who underwent emergency stenting after a diagnosis of myocardial infarction within 24 hours (STEMI, NSTEMI can be enrolled after 24 hours)
7. Who can not comply with the research plan
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method cardiac death;Target vessel myocardial infarction;STEMI and NSTEMI- Including periprocedural myocardial infarction;Ischemic driven target vessel revascularization
- Secondary Outcome Measures
Name Time Method All death;STEMI and NSTEMI-periprocedural MI;Target lesion revascularization (TLR);target vessel revascularization (Non-TVR),;Stent thrombosis